Document:

Form of Notice to Executive Officers

 Exhibit 10.1 
 Analogic Corporation 
 Annual Incentive Plan for Fiscal Year 2013

  
  

 

			
	Employee:	  	Supervisor:
	Title:	  	Target Level (% of salary):
	Plan Year:	  	

  
  
 Congratulations! Analogic Corporation (the “Company”) has selected you to participate in its Annual Incentive Plan (the “Plan”) for Fiscal Year 2013. A summary of the terms of the
Plan, as it applies to you, is shown below*: 
  

	1.	Eligibility to Earn an Award 

 You will be eligible to earn an award under the Plan if all of the following conditions apply: 
  

	 	a)	Analogic achieves at least 91.4% of its Non-GAAP Earnings per Share (EPS) budget for fiscal year 2013; 

 

	 	b)	you are an employee of the Company on July 31, 2013,** or your employment is terminated involuntarily after January 31, 2013 and you are eligible for Severance
Benefits. 

  

	2.	Performance Factors (see attachment) 

 The Target Level for your award is listed above. Your actual award may be greater or less than the Target Level, depending on the Company’s performance for the Plan year. If you are eligible to
receive an award, your final award amount will be determined based upon the following performance factors: 
  

	 	a)	Analogic Non-GAAP EPS - 60% of your award shall be determined by Analogic’s year-end results for Non-GAAP EPS relative to budget for fiscal year 2013.

  

	 	b)	Analogic Revenue - 30% of your award shall be determined by Analogic’s year-end results for Revenue relative to budget for fiscal year 2013.

  

	 	c)	Analogic Non-GAAP Return on Invested Capital (ROIC) - 10% of your award shall be determined by Analogic’s year-end results for Non-GAAP ROIC relative to
budget for fiscal year 2013. 

  

	3.	Determining Your Award 

  

	 	a)	Your award will be equal to your Target Level multiplied by your Eligible Base Earnings, adjusted for the actual performance measures relative to budget attained for
2013. “Eligible Base Earnings” means total base salary payments (including vacation, sick, and holiday pay) made through Company payroll for the Plan year. Payments made to employees during approved medical leaves of absence are excluded.

  

	 	b)	Actual awards will range from 0 to two (2) times the Target Level for the performance factors. 

 

	 	c)	If you are not eligible for an award for the entire 2013 fiscal year or if your Target Level changes during the Plan year, your award will be prorated based on the
number of months that you were eligible to receive the award. 

 This document is not an employment agreement, and
terms of employment are unaffected because of this document. Equitable adjustments will be made to exclude the impact of acquisitions or divestitures during the performance period. The Company reserves the right to adjust awards up or down in its
discretion based on exceptional circumstances. If Analogic Non-GAAP EPS is less than 91.4% of budget, no awards will be earned under this Plan. 
  

	*	For more information concerning the Plan, please contact the Human Resources Department. 

	**	Because payment of an award under the Plan is determined in part upon the Company’s performance during the 2013 Fiscal Year, the payment date of any award will be
after the completion of fiscal year 2013, as determined in the sole discretion of the Company’s Compensation Committee. 

 Analogic Corporation 

Annual Incentive Plan for Fiscal Year 2013 
  

					
	Target Level (% of Salary):	  		  	Annual Salary as of 10/29/2012:
			
		  		  	Target Bonus as of 10/29/2012:
	Performance Factors	  		  	
			
	Analogic Non-GAAP EPS:	  	60% of award	  	Target Amount as of 10/29/2012:
			
	Analogic Revenue:	  	30% of award	  	Target Amount as of 10/29/2012:
			
	Analogic Non-GAAP ROIC:	  	10% of award	  	Target Amount as of 10/29/2012:

 If you are eligible to receive an award under the Plan, the following charts describe how the amount of your award will
be determined based upon the Company’s financial performance. 
  

	a.	Analogic Non-GAAP Earnings per Share vs. Fiscal Year 2013 Budget 

  

																					
	 % of Budget
	  	< 91.4% of
Budget	 	91.4% of
Budget	 	100% of
Budget	 	3 115.2% 
of
Budget
	 % of Target
	  	 	 	0	%  	 	 	 	25	%  	 	 	 	100	%  	 	 	 	200	%  
					
	 Award Amount
	  	 	$	0	 	 	 				 	 				 	 			

  

	b.	Revenue vs. Fiscal Year 2013 Budget 

  

																					
	 % of Budget
	  	< 93% of
Budget	 	93% of
Budget	 	100% of
Budget	 	3 105.4% 
of
Budget
	 % of Target
	  	 	 	0	%  	 	 	 	25	%  	 	 	 	100	%  	 	 	 	200	%  
					
	 Award Amount
	  	 	$	0	 	 	 				 	 				 	 			

  

	c.	Non-GAAP ROIC vs. Fiscal Year 2013 Budget 

  

																					
	 % of Budget
	  	< 92.7% of
Budget	 	92.7% of
Budget	 	100% of
Budget	 	3 106% 
of
Budget
	 % of Target
	  	 	 	0	%  	 	 	 	25	%  	 	 	 	100	%  	 	 	 	200	%  
					
	 Award Amount
	  	 	$	0	 	 	 				 	 				 	 			

  

	•	 	 Intermediate results on above financial measures will be interpolated. 

 

	•	 	 Your target bonus, and all variations thereof, are based on a full fiscal year in your current position and will be prorated to reflect the actual
amount of time you are in your current role during fiscal 2013. See Section 3(c) of this document. 

  

	•	 	 If Analogic Non-GAAP EPS is <91.4% of budget, no awards will be earned under the planExhibit 10.15

 Exhibit 10.15 
 WHEELER REAL ESTATE INVESTMENT TRUST, INC. 
 Public Offering of Shares of
Common Stock 
 Maximum: 4,000,000 Shares 
 Minimum: 3,000,000 Shares 
 PLACEMENT AGREEMENT 

November 16, 2012 
 Wellington
Shields & Co., LLC and 
 Capitol Securities Management, Inc. (the “Placement Agents”) 

c/o Wellington Shields & Co., LLC 
 140
Broadway 
 New York, NY 10005 
 Ladies
and Gentlemen: 
 The undersigned, Wheeler Real Estate Investment Trust, Inc., a Maryland corporation (the
“Company”), hereby confirms its agreement with you (unless otherwise defined herein, the term “you” shall collectively refer to the Placement Agents) as follows: 

1. Introduction. This Agreement sets forth the understandings and agreements between the Company and you whereby, subject
to the terms and conditions herein contained, you will offer to sell, on a “best efforts basis” on behalf of the Company (the “Offering”), a minimum of 3,000,000 shares and a maximum of 4,000,000 shares of the common stock
of the Company, par value $0.01 (the “Shares”). The terms of the offering will be $5.25 per share. Capitalized terms used herein and not otherwise defined herein shall have the meanings ascribed to them in the prospectus prepared by
the Company and dated November 13, 2012 (the “Prospectus”) (defined again in Section 2(a)). 
 2.
Representations and Warranties of the Company. The Company makes the following representations and warranties to you: 
 (a) Registration Statement and Prospectus. The Company has prepared and filed with the Securities and Exchange Commission (the “Commission”) a registration statement on Form S-11
(File No. 333-177262) (as defined below, the “Registration Statement”) conforming to the requirements of the Securities Act of 1933, as amended (the “1933 Act”), and the applicable rules and regulations (the
“Rules and Regulations”) of the Commission. Such amendments to such Registration Statement as may have been required prior to the date hereof have been filed with the Commission, and such amendments have been similarly prepared.
Copies of the Registration Statement, any and all amendments thereto prepared and filed with the Commission, and the exhibits, financial statements and schedules, as finally amended and 

 
revised, have been delivered to you for review. The term “Registration Statement” as used in this Agreement shall mean the Company’s Registration Statement on Form S-11, including
the Prospectus, any documents incorporated by reference therein, and all financial schedules and exhibits thereto, as amended on the date that the Registration Statement becomes effective, and any registration statement related to the Offering that
is filed pursuant to Rule 462(b) of the 1933 Act. The term “Prospectus” (previously defined) as used in this Agreement shall mean the prospectus relating to the Shares in the form in which it was filed with the Commission pursuant
to Rule 424(b) of the 1933 Act or, if no filing pursuant to Rule 424(b) of the 1933 Act is required, shall mean the form of the final prospectus included in the Registration Statement when the Registration Statement becomes effective. The terms
“effective date” and “effective” refer to the date the Commission declares the Registration Statement effective pursuant to Section 8 of the 1933 Act. 

(b) Adequacy of Disclosure. When the Registration Statement shall become effective, when the Prospectus is first filed pursuant
to Rule 424(b) of the Rules and Regulations, when any amendment to the Registration Statement becomes effective, when any supplement to the Prospectus is filed with the Commission and on the Closing Date (as hereinafter defined), (i) the
Registration Statement, the Prospectus and any amendments thereof and supplements thereto will conform in all material respects with the applicable requirements of the 1933 Act and the Rules and Regulations, and (ii) neither the Registration
Statement, the Prospectus nor any amendment or supplement thereto will contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein not
misleading; provided, however, that this representation and warranty shall not apply to any statements or omissions made in reliance upon and in conformity with information furnished in writing to the Company by you expressly for use in the
Registration Statement. 
 (c) No Stop Order. The Commission has not issued any order preventing or suspending the use
of the Prospectus with respect to the Shares, and no proceedings for that purpose have been instituted or, to the Company’s knowledge, threatened by the Commission or the state securities or blue sky authority of any jurisdiction. 

(d) Company; Organization and Qualification. The Company has been duly incorporated and is validly existing and of active status
as a corporation under the laws of the State of Maryland with all requisite corporate power and authority to enter into this Agreement, to conduct its business as now conducted and as proposed to be conducted, and to own and operate its properties,
investments and assets, as described in the Registration Statement and Prospectus. The Company is not in violation of any provision of its charter, bylaws, as amended, or other governing documents and is not in default under or in breach of, and
does not know of the occurrence of any event that with the giving of notice or the lapse of time or both would constitute a default under or breach of, any term or condition of any material agreement or instrument to which it is a party or by which
any of its properties, investments or assets is bound, except as disclosed in the Registration Statement and Prospectus or except as would not, individually or in the aggregate, result in any material adverse effect on the business, financial
position, shareholders’ equity or results of operations of the Company (a “Material Adverse Effect”). Except as noted in the Prospectus, the Company does not own or control, directly or indirectly, any other corporation,
association, or other entity. The Company has furnished to you 

  
 2 

 
copies of its charter, bylaws, as amended, and all other governing documents, and all such copies are true, correct and complete and contain all amendments thereto through the date of this
Agreement. 
 (e) Validity of Shares. The Shares have been duly and validly authorized by the Company and upon issuance
against payment therefor as provided herein, will be validly issued, fully paid and non-assessable, and will conform to the description thereof contained in the Prospectus. No party has any preemptive rights with respect to any of the Shares or any
right of participation or first refusal with respect to the sale of the Shares by the Company. No person or entity holds a right to require or participate in the registration under the 1933 Act of the Shares pursuant to the Registration Statement.
Except as set forth in the Prospectus, no person holds a right to require registration under the 1933 Act of any security of the Company at any other time. The form of certificate evidencing the Shares complies with all applicable requirements of
Maryland law. 
 (f) Capitalization. As of the date of this Agreement, the authorized capital stock of the Company
consists of 15,000,000 shares of common stock, of which 0 shares are issued and outstanding and 500,000 shares of Series A Convertible preferred Stock, of which 183,500 are issued and outstanding. All shares of the issued and outstanding common and
preferred stock of the Company have been duly authorized, validly issued, fully paid and non-assessable. Except as disclosed in the Registration Statement and Prospectus (including any public filing incorporated by reference into the Prospectus),
there is no outstanding option, warrant or other right calling for the issuance of, and no commitment, plan or arrangement to issue, any shares of capital stock of the Company or any security convertible into or exchangeable for capital stock of the
Company. 
 (g) Full Power; Company. The Company has full legal right, power, and authority to enter into this Agreement
and the Escrow Agreement among the Company, SunTrust Bank, a Georgia banking corporation (the “Escrow Agent”) and you (the “Escrow Agreement”), to issue and deliver the Shares as provided herein and in the
Prospectus and to consummate the transactions contemplated herein and in the Prospectus. Each of this Agreement and the Escrow Agreement have been duly authorized, executed, and delivered by the Company and constitutes a valid and binding agreement
of the Company, enforceable in accordance with its terms, except to the extent that enforceability may be limited by (i) bankruptcy, insolvency, moratorium, liquidation, reorganization, or similar laws affecting creditors’ rights
generally, regardless of whether such enforceability is considered in equity or at law, (ii) general equity principles, and (iii) limitations imposed by federal and state securities laws or the public policy underlying such laws regarding
the enforceability of indemnification or contribution provisions. 
 (h) Disclosed Agreements. All agreements between or
among the Company and third parties expressly referenced in the Prospectus are legal, valid, and binding obligations of the Company, enforceable against the Company in accordance with their respective terms, except to the extent enforceability may
be limited by (i) bankruptcy, insolvency, moratorium, liquidation, reorganization, or similar laws affecting creditors’ rights generally, regardless of whether such enforceability is considered in equity or at law, (ii) general equity
principles and (iii) limitations imposed by federal or state securities laws or the public policy underlying such laws regarding the enforceability of indemnification or contribution provisions. 

  
 3 

 (i) Consents. Except as disclosed in the Registration Statement and Prospectus, each
consent, approval, authorization, order, license, certificate, permit, registration, designation or filing by or with any governmental agency or body or any other third party necessary for the valid authorization, issuance, sale and delivery of the
Shares, the execution, delivery and performance of this Agreement and the consummation by the Company of the transactions contemplated hereby and by the Registration Statement and Prospectus, except such as may be required under the 1933 Act, the
Securities Exchange Act of 1934, as amended (the “1934 Act”), or under state securities laws has been made or obtained and is in full force and effect. 
 (j) Litigation. There is not pending or, to the knowledge of the Company, threatened or contemplated, any action, suit, proceeding, inquiry, or investigation before or by any court or any
governmental authority or agency to which the Company may be a party, or to which any of the properties or rights of the Company may be subject, that is not described in the Registration Statement and Prospectus and (i) that may reasonably be
expected to result in a Material Adverse Effect, (ii) that may reasonably be expected to materially adversely affect any of the material properties of the Company or (iii) that may reasonably be expected to adversely affect the
consummation of the transactions contemplated by this Agreement. 
 (k) Financial Statements. The financial statements
of the Company together with related schedules and notes included in the Registration Statement and Prospectus by incorporation by reference fairly present in all material respects the consolidated financial position of the Company as of the dates
indicated and the results of operations and cash flows for the periods specified. Such financial statements have been prepared in conformity with generally accepted accounting principles in the United States (“US GAAP”) applied on a
consistent basis during the periods involved. The financial statement schedules, if any, incorporated by reference into the Registration Statement fairly present in all material respects the information shown therein and have been compiled on a
basis consistent with the financial statements, the Registration Statement and the Prospectus. The unaudited financial information (including the related notes) incorporated by reference into the Prospectus complies as to form in all material
respects to the applicable accounting requirements of the 1933 Act and the Rules and Regulations, and management of the Company believes that the assumptions underlying any adjustments are reasonable. Such adjustments have been properly applied to
the historical amounts in the compilation of the information and such information fairly presents in all material respects with respect to the Company the financial position, results of operations and other information purported to be shown therein
at the respective dates and for the respective periods specified. 
 (l) Independent Accountants. Cherry,
Bekaert & Holland, L.L.P., who have audited certain financial statements of the Company and its subsidiaries, are independent public accountants as required by the 1933 Act and the Rules and Regulations. 

(m) Disclosed Liabilities. The Company has not sustained, since January 1, 2011, any material loss or interference with its
business from fire, explosion, flood, hurricane, accident, or other calamity, whether or not covered by insurance, or from any labor dispute or arbitrators’ or court or governmental action, order, or decree, otherwise than as set forth or
contemplated in the Registration Statement and Prospectus. Since the respective dates as of which information is given in the Registration Statement and Prospectus, and except as otherwise stated in the

  
 4 

 
Registration Statement and Prospectus, there has not been (i) any material change in the capital stock, long-term debt, obligations under capital leases, or short-term borrowings of the
Company, (ii) any material adverse change, or any development that could reasonably be expected to result in a prospective material adverse change in the business, properties, assets, results of operations or condition (financial or other) of
the Company, (iii) any liability or obligation, direct or contingent, incurred or undertaken by the Company that is material to the business or condition (financial or other) of the Company, except for liabilities or obligations incurred in the
ordinary course of business, (iv) any declaration or payment of any dividend or distribution of any kind on or with respect to the capital stock of the Company, or (v) any transaction that is material to the Company, except transactions in
the ordinary course of business or as otherwise disclosed in the Registration Statement and Prospectus. 
 (n) Required
Licenses and Permits. Except as disclosed in the Prospectus, the Company owns, possesses, has obtained or in the ordinary course of business will obtain, and has made available for your review, all material permits, licenses, franchises,
certificates, consents, orders, approvals, and other authorizations of governmental or regulatory authorities as are necessary to own or lease, as the case may be, and to operate its properties and to carry on its business as presently conducted, or
as contemplated in the Prospectus to be conducted (the “Permits”), except for such permits, licenses, franchises, certificates, consents, orders, approvals, and other authorizations, the failure of which to have or maintain would
not, individually or in the aggregate, have a Material Adverse Effect, and the Company has not received any notice of proceedings relating to revocation or modification of any such Permits, except where such revocation or modification would not have
a Material Adverse Effect. 
 (o) Internal Accounting Measures. The Company maintains an effective system of
“disclosure controls and procedures” (as defined in Rule 13a-15(e) of the 1934 Act) that complies with the requirements of the 1934 Act and that has been designed to ensure that information required to be disclosed by the Company in
reports that it files or submits under the 1934 Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures designed to ensure that such
information is accumulated and communicated to the Company’s management as appropriate to allow timely decisions regarding required disclosure. The Company has carried out evaluations of the effectiveness of its disclosure controls and
procedures as required by Rule 13a-15 of the 1934 Act. The Company also maintains a system of “internal control over financial reporting” (as defined in Rule 13a-15(f) of the 1934 Act) that complies with the requirements of the 1934 Act
and has been designed by, or under the supervision of, the Company’s principal executive and principal financial officers, or persons performing similar functions, to provide reasonable assurance regarding the reliability of financial reporting
and the preparation of financial statements for external purposes in accordance with US GAAP, including, but not limited to, internal accounting controls sufficient to provide reasonable assurance that: (i) transactions are executed in
accordance with management’s general or specific authorizations; (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with US GAAP and to maintain asset accountability;
(iii) access to assets is permitted only in accordance with management’s general or specific authorization; and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate
action is taken with respect to any differences. Based on the Company’s most recent evaluation of its internal controls over financial reporting pursuant to Rule 13a-15(c) of the 1934 

  
 5 

 
Act, except as disclosed in the Registration Statement and the Prospectus, there are no material weaknesses in the Company’s internal controls. The Company’s auditors and the Audit
Committee of the Board of Directors of the Company have been advised of: (i) all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which have adversely affected or are
reasonably likely to adversely affect the Company’s ability to record, process, summarize and report financial information; and (ii) any fraud, whether or not material, that involves management or other employees who have a significant
role in the Company’s internal controls over financial reporting. Upon the effectiveness of the Registration Statement, the Company will be in compliance in all material respects with all provisions of the Sarbanes-Oxley Act of 2002 that are
effective and applicable to the Company as of such date as an “issuer” as defined under the Sarbanes-Oxley Act of 2002. 
 (p) Taxes. The Company has properly filed all necessary federal, state, local, and foreign income tax returns required to be filed by it and has paid all taxes shown as due and payable thereon (or
has obtained appropriate extensions), except for taxes that are being contested in good faith and for which adequate reserves have been established in the Company’s financial statements. No tax deficiency has been asserted or, to the knowledge
of the Company, threatened to be asserted against the Company. The Company has made appropriate provisions in the financial statements included in the Registration Statement and Prospectus by incorporation for all tax liabilities of the Company that
have not been determined as of such date, except to the extent it would not have a Material Adverse Effect. 
 (q)
Compliance with Instruments. The execution, delivery and performance of this Agreement and the Escrow Agreement, the compliance with the terms and provisions hereof and the consummation of the transactions contemplated herein, therein and in
the Registration Statement and Prospectus by the Company, do not and will not violate or constitute a breach of, or default under: (i) the charter, bylaws, or other governing document of the Company, as amended; (ii) any of the terms,
provisions, or conditions of any material instrument, agreement, or indenture to which the Company is a party or by which it is bound or by which its business, assets, investments or properties may be affected; or (iii) any order, statute,
rule, or regulation applicable to the Company, or any of its business, investments, assets or properties, of any court or (to the knowledge of the Company) any governmental authority or agency having jurisdiction over the Company, or any of its
business, investments, properties or assets; and to the knowledge of the Company do not and will not result in the creation or imposition of any lien, charge, claim, or encumbrance upon any property or asset of the Company. 

(r) Insurance. The Company maintains insurance (issued by insurers of recognized financial responsibility) of the types and in
the amounts generally deemed adequate for its business and, to the knowledge of the Company, consistent with insurance coverage maintained by similar companies and similar businesses, all of which insurance is in full force and effect. 

(s) Work Force. To the knowledge of the Company, no general labor problem exists or is imminent with the employees of the
Company. 
 (t) Securities Matters. The Company and its officers, directors, or affiliates have not taken and will not
take, directly or indirectly, any action designed to, or that might reasonably be expected to, cause or result in or constitute the stabilization or manipulation of any security of the Company or to facilitate the sale or resale of the Shares.

  
 6 

 (u) Payment of Commissions and Fees. Except as stated in or contemplated by the
Prospectus, neither the Company nor any affiliate of the Company has paid or awarded, nor will any such person pay or award, directly or indirectly, any commission or other compensation to any person engaged to render investment advice to a
potential purchaser of Shares as an inducement to advise the purchase of Shares. 
 (v) Company Intellectual Property.
Except as disclosed in the Registration Statement and Prospectus: 
 (i) the Company owns, possesses, licenses or has other
rights to use the patents and patent applications, copyrights, trademarks, service marks, trade names, technology, know-how (including trade secrets and other unpatented and/or unpatentable proprietary rights) and other intellectual property (or
could acquire such intellectual property upon commercially reasonable terms) necessary to conduct its business in the manner in which it is being conducted (collectively, the “Company Intellectual Property”); 

(ii) to the Company’s knowledge, none of the patents owned or licensed by the Company, if any, is unenforceable or invalid, and, to
the Company’s knowledge, none of the patent applications owned or licensed by the Company would be unenforceable or invalid if issued as patents; 
 (iii) the Company is not obligated to pay a royalty, grant a license, or provide other consideration to any third party in connection with the Company Intellectual Property other than as disclosed in the
Prospectus and other than for in-bound “shrink-wrap” end-user licenses and similar generally available commercial end-user licenses; 
 (iv) the Company has not received any notice of violation or conflict with rights of others with respect to the Company Intellectual Property; 

(v) there are no pending or, to the Company’s knowledge, threatened actions, suits, proceedings or claims by others that the
Company is infringing any patent, trade secret, trade mark, service mark, copyright or other intellectual property or proprietary right; and 
 (vi) the products or processes of the Company referenced in the Prospectus do not, to the knowledge of the Company, violate or conflict with any intellectual property or proprietary right of any third
person. 
 (w) Forward Looking Statement. No forward-looking statement (within the meaning of Section 27A of the
1933 Act and Section 21E of the 1934 Act) contained in or incorporated by reference into the Registration Statement or the Prospectus has been made or reaffirmed without a reasonable basis or has been disclosed other than in good faith.

 (x) Industry and Market Statistics. The industry-related and market-related statistics obtained from independent
industry publications and reports and included in the Registration Statement and the Prospectus agree with the sources from which they are derived. The Company has provided copies of all such sources to you. 

  
 7 

 (y) Company/Director Relationships. No relationship exists between or among the
Company and any director, officer, stockholder or affiliate of the Company which is required by the 1933 Act and the Rules and Regulations to be described in the Registration Statement or the Prospectus which is not so described and described as
required in material compliance with such requirement. There are no outstanding loans, advances (except advances for business expenses in the ordinary course of business) or guarantees of indebtedness by the Company to or for the benefit of any of
the officers or directors of the Company or any of their respective family members. 
 (z) Subordination Agreement. On
or before the effective date, the Company will enter into one or more Subordination Agreements with Jon Wheeler and any other individuals as the Placement Agent may require in such form as is filed with the effective Registration Statement.

 (aa) Relationships with FINRA Members. The Company has not sold any securities to any person or entity nor is there
any beneficial owner of the issuer’s unregistered equity securities, that acquired said securities during the 180-day period immediately preceding the effective date, that has an association or affiliation with any member of the Financial
Industry Regulatory Authority (“FINRA”). 
 3. Representations and Warranties of Placement Agent.
Each of you represents and warrants to the Company that: 
 (a) FINRA Membership. You are a member, in good standing, of
the Financial Industry Regulatory Authority (“FINRA”), and are duly registered as a broker-dealer under the 1934 Act, and under the laws of each state in which you propose to offer the Shares, except where such registration would
not be required by law. 
 (b) Full Power. This Agreement has been duly authorized, executed and delivered by you and is
a valid and binding agreement of you, enforceable in accordance with its terms, except to the extent that enforceability may be limited by (i) bankruptcy, insolvency, moratorium, liquidation, reorganization, or similar laws affecting
creditors’ rights generally, regardless of whether such enforceability is considered in equity or at law, (ii) general equity principles, and (iii) limitations imposed by federal and state securities laws or the public policy
underlying such laws regarding the enforceability of indemnification or contribution provisions. 
 (c) Compliance with
Instruments. The consummation of the transactions contemplated by the Prospectus relating to the Offering will not violate or constitute a breach of, or default under, your articles of incorporation or bylaws, or any material instrument,
agreement, or indenture to which you are a party, or violate any order, statute, rule or regulation applicable to you of any court, federal or state regulatory body or administrative agency having jurisdiction over you or your property. 

(d) Offering. You will comply with all relevant provisions of the 1933 Act in connection with the Prospectus, you will conduct
all offers and sales of the Shares in compliance with the relevant provisions of the Act and various state securities laws and regulations. 

  
 8 

 4. Sale of Shares. 

(a) Exclusive Agency. Upon the basis of the representations and warranties of the Company and the Placement Agents set forth in
this Agreement, the Company engages you and you agree to act as the Company’s exclusive agents, on a best efforts basis, in connection with the offer and sale by the Company during the Offering Period (as defined in Section 4(c) below) of
a minimum of 3,000,000 Shares and a maximum of 4,000,000 Shares. Subject to your commitment to sell the Shares on a “best efforts basis” as provided herein, nothing in this Agreement shall prevent you from entering into an agency
agreement, underwriting agreement, or other similar agreement governing the offer and sale of securities with any other issuer of securities, and nothing contained herein shall be construed in any way as precluding or restricting your right to sell
or offer for sale securities issued by any other person, including securities similar to, or competing with, the Shares. It is understood between the parties that there is no firm commitment by you to purchase any or all of the Shares and you shall
have no authority to bind the Company in respect of the sale of any Shares. You may retain other brokers or dealers (“Selected Dealers”) who are members in good standing of FINRA and registered in any states in which the Offering is
conducted to assist you and to act as subagents on your behalf in connection with the offering and sale of the Shares and you may enter into agreements for the offer and sale of the Shares adopting such provisions of this Agreement for the benefit
of the Selected Dealers as you deem appropriate; provided, however, that the Company will only be obligated to pay you for services rendered hereunder. Each Selected Dealer will indemnify the Company on terms and conditions similar to those set
forth in Section 8(b) of this Agreement for any statements, acts, or omissions by such Selected Dealer in connection with the offer or sale of the Shares not expressly authorized by the Company or the Placement Agent and for any material
misrepresentation or material breach of warranty or covenant or other breach by such Selected Dealer of its agreement with the Placement Agent, or any failure or alleged failure by such Selected Dealer to comply with applicable laws, rules, and
regulations. 
 (b) Obligation to Offer Shares. Your obligation to offer the Shares is subject to receipt by you of
written advice from the Commission that the Registration Statement is effective, is subject to the Shares being qualified for offering under applicable laws in the states as may be reasonably designated by you, is subject to the absence of any
prohibitory action by any governmental body, agency, or official, and is subject to the terms and conditions contained in this Agreement and in the Registration Statement. 
 (c) Offering Termination Date. The “Offering Period” shall commence on the day that the Prospectus is first made available to prospective investors in connection with the offering
for sale of the Shares and shall continue until the “Offering Termination Date,” which shall be the earliest of (i) the date on which the maximum number of Shares (4,000,000) offered have been sold, (ii) the date on
which the Company withdraws the Registration Statement, (iii) the date on which the Company files a post-effective amendment to the Registration Statement deregistering any unsold Shares, (iv) December 22, 2012, or (v) such other date
mutually agreeable to the parties hereto. 

  
 9 

 (d) Escrow Agent. Proceeds from the sale of the Shares will be deposited into an
escrow account (the “Escrow Account”) with the Escrow Agent pursuant to the Escrow Agreement, until a minimum of 3,000,000 Shares have been sold. The Escrow Agreement includes the requirement, among other concepts, that all funds
received from the sale of the Shares will be promptly deposited in the Escrow Account for the investors in the offering upon the receipt of funds by the Placement Agent’s by or before noon of the next business day following the sale of the
Shares, i.e. the date of closing. The form of the Escrow Agreement is attached as an exhibit to the Registration Statement. All payments of, from or on account of such funds shall be made pursuant to the Escrow Agreement. The Company and you each
shall have the option to accept or reject any offer to purchase Shares from prospective purchasers, in whole or in part. The Company shall notify prospective purchasers as to whether their offers to purchase Shares have been accepted. Any funds
relating to an offer to purchase Shares that is not accepted, in whole or in part, shall be promptly returned by the Escrow Agent. In the event the Company does not sell a minimum of 3,000,000 Shares by December 22, 2012, escrowed funds will be
promptly returned to investors without interest or deduction. In the event that a minimum of 3,000,000 Shares are sold by December 22, 2012, the Company will close on those funds received and promptly issue the Shares, all according to the
terms of the Escrow Agreement. 
 (e) Closing Date. As and when the closing of the Offering is effected, which shall be
on or before the Offering Termination Date, and proceeds from the Shares sold are received and accepted, on such date (the “Closing Date”) and at such time and place as determined by you (which determination shall be subject to the
satisfaction on such date of the conditions contained herein), the funds received from purchasers will be delivered by the Escrow Agent to the Company, by wire transfer of immediately available funds, on the Closing Date. 

(f) Selling Commissions. In consideration for your execution of this Agreement and for the performance of your obligations
hereunder, the Company agrees to pay you, by wire transfer of immediately available funds on the Closing Date, if any, a selling commission computed at the rate of seven percent (7%) of the public offering price of the Shares sold in the
Offering to purchasers who were solicited by you and who were not referred to you by the Company officers, directors or affiliates. Wellington Shields & Co., LLC will allocate such fees among the Placement Agents in accordance with the
terms of the agreements among the Placement Agents. 
 (g) Finder’s Fees. Except as set forth in the Registration
Statement or Prospectus, neither you nor the Company, directly or indirectly, shall pay or award any finder’s fee, commission, or other compensation to any person engaged by a prospective purchaser for investment advice as an inducement to such
advisor to advise the purchase of the Shares or for any other purpose. 
 (h) Delivery of Shares. Delivery of the Shares
shall be made at your offices or at such other place as shall be agreed upon by the Company and you, on such date as you may request (each a “Date of Delivery”). Such securities shall be issued in such denominations and registered
in such names as you may request in writing at least three full business days before the Date of Delivery. 

  
 10 

 5. Covenants. 

(a) Covenants of the Company. The Company covenants with you as follows: 

(i) Notices. Until the Offering Termination Date, the Company immediately will notify you, and confirm such notice in writing,
(A) of any fact that would make inaccurate any representation or warranty by the Company, and (B) of any change in facts on which your obligation to perform under this Agreement is dependent. 

(ii) Effectiveness of Registration Statement. The Company will use its best efforts to cause the Registration Statement to become
effective (if not yet effective at the date and time this Agreement is executed and delivered by the parties hereto). If the Company elects to rely upon Rule 430A of the Rules and Regulations or the filing of the Prospectus is otherwise required
under Rule 424(b) of the Rules and Regulations, and subject to the provisions of Section 5(a)(iii) of this Agreement, the Company will comply with the requirements of Rule 430A and will file the Prospectus, properly completed, pursuant to the
applicable provisions of Rule 424(b) within the time prescribed. The Company will notify you immediately, and confirm the notice in writing, (A) when the Registration Statement, or any post-effective amendment to the Registration Statement,
shall have become effective, or any supplement to the Prospectus, or any amended Prospectus shall have been filed, (B) of the receipt of any comments from the Commission, (C) of any request by the Commission to amend the Registration
Statement or amend or supplement the Prospectus or for additional information, and (D) of the issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement or the suspension of the qualification of the
Shares for offering or sale in any jurisdiction, or of the institution or threatening of any proceeding for any such purposes. The Company will use all reasonable efforts to prevent the issuance of any such stop order or of any order preventing or
suspending such use and, if any such order is issued, to obtain the withdrawal thereof at the earliest possible moment. 

(iii) Amendments to Registration Statement and Prospectus. The Company will not at any time file or make any amendment to the
Registration Statement, or any amendment or supplement (A) to the Prospectus, if the Company has not elected to rely upon Rule 430A, or (B) if the Company has elected to rely upon Rule 430A, to either the Prospectus included in the
Registration Statement at the time it becomes effective or to the Prospectus filed in accordance with Rule 424(b), in either case if you shall not have previously been advised and furnished a copy thereof a reasonable time prior to the proposed
filing, or if you or your counsel shall reasonably object to such amendment or supplement; provided, however, that if you shall have objected to such amendment or supplement, you shall cease your efforts to sell the Shares until an amendment or
supplement is filed. 
 (iv) Delivery of Registration Statement. The Company has delivered to you or will deliver to
you, without expense to you, at such locations as you shall request, as soon as the Registration Statement or any amended Registration Statement is available, such number of signed copies of the Registration Statement as originally filed and of
amended Registration Statements, if any, copies of all exhibits and documents filed therewith, and signed copies of all consents and certificates of experts, as you may reasonably request. 

  
 11 

 (v) Delivery of Prospectus. The Company will deliver to you at its expense, as soon
as the Registration Statement shall have become effective and thereafter from time to time as requested during the period when the Prospectus is required to be delivered under the 1933 Act, such number of copies of the Prospectus (as supplemented or
amended) as you may reasonably request. Until the Offering Termination Date, the Company will comply to the best of its ability with the 1933 Act and the Rules and Regulations so as to permit the completion of the distribution of the Shares as
contemplated in this Agreement and in the prospectus. If the delivery of a prospectus is required at any time prior to the expiration of nine months after the time of issue of the Prospectus in connection with the offering or sale of the Shares and
if at such time any events shall have occurred as result of which the Prospectus as then amended or supplemented would include an untrue statement of a material fact or omit to state any material fact necessary in order to make the statements
therein, in light of the circumstances under which they were made when such Prospectus is delivered not misleading or, if for any reason it shall be necessary during the same period to amend or supplement the Prospectus in order to comply with the
1933 Act, the Company will notify you and upon your request prepare and furnish without charge to you and to any dealer in securities as many copies as you may from time to time reasonably request of an amended Prospectus or a supplement to the
Prospectus that will correct such statement or omission or effect such compliance, and in case you are required to deliver a prospectus in connection with sales of any of the Shares, upon your request but at your expense, the Company will prepare
and deliver to you as many copies as you may request of an amended or supplemented Prospectus complying with Section 10(a)(3) of the 1933 Act. 
 (vi) Blue Sky Qualification. The Company, in good faith and in cooperation with you, will use its best efforts to qualify the Shares for offering and sale under (or obtain exemptions from the
application of) the applicable “blue sky” or securities laws of such jurisdictions as you from time to time may reasonably designate and to maintain such qualifications in effect until the date on which the Company ceases to be obligated
to maintain the effectiveness of the Registration Statement; provided, however, that the Company shall not be obligated to qualify as a foreign corporation in any jurisdiction in which it is not so qualified or to make any undertakings in respect of
doing business in any jurisdiction in which it is not otherwise so subject or to take any action that would subject it to general service of process in any such jurisdiction where it is not currently qualified or where it would be subject to
taxation as a foreign corporation where it is not now so subject. The Company will file such statements and reports as may be required by the laws of each jurisdiction in which the Shares have been qualified as above provided. 

(vii) Application of Net Proceeds. The Company will apply the net proceeds received from the sale of the Shares in all material
respects as set forth in the Prospectus under the caption “Use of Proceeds.” 
 (viii) Cooperation with Your Due
Diligence. At all times prior to the Offering Termination Date, the Company will cooperate with you in such investigation as you may make or cause to be made of all the business and operations of the Company in connection with the sale of the
Shares, and will make available to you in connection therewith such information in its possession as you may reasonably request, all of which you agree to safeguard as the confidential information of the Company and to refrain from using for any
purpose adverse to the interests of the Company. 

  
 12 

 (ix) Transfer Agent. The Company will act as or otherwise maintain a transfer agent
and, if necessary under applicable jurisdictions, a registrar (which may be the same entity as the transfer agent) for the Shares. 
 (x) NASDAQ. The Company will use its reasonable best efforts to have the Shares listed on the NASDAQ Capital Market. 
 (xi) Actions of Company, Officers, Directors, and Affiliates. The Company will not, and will use its best efforts to cause its officers, directors, and affiliates not to (i) take, directly or
indirectly, prior to termination of the Offering contemplated by this Agreement, any action designed to stabilize or manipulate the price of any security of the Company, or that may cause or result in, or that might in the future reasonably be
expected to cause or result in, the stabilization or manipulation of the price of any security of the Company, (ii) other than under this Agreement, sell, bid for, purchase, or pay anyone any compensation for soliciting purchases of the Shares
or (iii) pay or agree to pay to any person any compensation for soliciting any order to purchase any other securities of the Company. 
 (xii) Relationships with FINRA Members. The Company will not sell any securities to any person or entity nor will there be any beneficial owner of the issuer’s unregistered equity securities,
during the period within 90-days following the effectiveness of the Registration Statement, that has an association or affiliation with any member of the Financial Industry Regulatory Authority (“FINRA”). 

(xiii) Subordination Agreement. The Company will enforce the terms of the Subordination Agreement with Jon Wheeler and any other
signatories to such agreement for three years (or until such time as the contract expires by its terms) in such form as is filed with the effective Registration Statement. 
 (b) Your Covenants. You covenant with the Company as follows: 
 (i)
Information Provided. You have not provided and will not provide to the purchasers of Shares any written or oral information regarding the business of the Company, including any representations regarding the Company’s financial condition
or financial prospects, other than such information as is contained in the Prospectus. You further covenant that you will use your best efforts to comply in the offering of the Shares with such purchaser suitability requirements as may be imposed by
state securities or blue sky requirements. 
 (ii) Prospectus Supplements. Until the termination of this Agreement, if
any event affecting the Prospectus, the Company or you shall occur which, in the opinion of counsel to the Company, should be set forth in a supplement to the Prospectus, you agree to distribute each supplement of the Prospectus to each person who
has previously received a copy of the Prospectus from you and you further agree to include such supplement in all future deliveries of the Prospectus. You agree that following notice from the Company that a supplement to the Prospectus is necessary,
you will cease further efforts to sell the Shares until such a supplement is prepared and delivered to you. 
 (iii)
Compliance with Laws, Etc. In connection with or in contemplation of your sale of the Shares, you will comply in all material respects with applicable federal and 

  
 13 

 
state laws, rules and regulations and the rules and regulations of applicable self- regulatory organizations (provided, however, that you shall be deemed not to have breached this covenant if
your failure to so comply is based on a breach by the Company of any of its representations, warranties or covenants contained in this Agreement and you shall have complied with Section 5(b)(ii) above). 

6. Payment of Expenses. Except as is expressly provided to the contrary in Section 10 of this Agreement, the Company
hereby agrees that it will pay all fees and expenses incident to the performance of its obligations under this Agreement (excluding fees and expenses of counsel for you, except as specifically set forth below), including (a) the preparation,
printing and filing of the Registration Statement (including financial statements and exhibits), as originally filed and as amended, the Prospectus and any amendments or supplements thereto, and the cost of furnishing copies thereof to you,
(b) the preparation, printing, and distribution of this Agreement, the certificates representing the Shares, any Blue Sky Memoranda, and any instruments relating to any of the foregoing, (c) the issuance and delivery of the Shares,
including any transfer taxes payable thereon, (d) the fees and disbursements of the Company’s counsel and accountants, (e) the qualification of the Shares under applicable securities laws in accordance with Section 5(a)(vi) of
this Agreement and any filing fee paid in connection with the review of the Offering by FINRA, including filing fees and fees and disbursements made in connection therewith and in connection with any Blue Sky Memoranda supplied to you by counsel for
the Company, (f) all costs, fees, and expenses in connection with the application for qualifying the Shares for quotation on the NASDAQ Capital Market, (g) the transfer agent’s and registrar’s fees, if any, and all miscellaneous
expenses referred to in the Registration Statement, (h) costs related to travel and lodging incurred by the Company and its representatives relating to meetings with and presentations to prospective purchasers of the Shares reasonably
determined by you to be necessary or desirable to effect the sale of the Shares to the public, (i) any escrow arrangements in connection with the transactions described herein, including any compensation or reimbursement to the Escrow Agent for
its services as such, and (j) all other costs and expenses incident to the performance of the Company’s obligations hereunder that are not otherwise specifically provided for in this Section 6. In addition, on the Closing Date, the
Company will pay you a non-accountable expense allowance not to exceed one and one-half percent (1.5%) of the public offering price of the Shares sold in the Offering (such expense allowance not to include any items prohibited by FINRA Rule
5110(f)(2)(A)). Except as otherwise set forth in Section 10 of this Agreement, no placement fees will be paid to you and none of your expenses will be reimbursed in the event that the Offering does not close. 

7. Conditions of Your Obligations. Your obligations hereunder shall be subject to, in your discretion, the following terms
and conditions: 
 (a) Effectiveness of Registration Statement. The Registration Statement shall have become effective
not later than 5:30 p.m. on the date of this Agreement or, at such later time or on such later date as you may agree to in writing; and as of the Closing Date no stop order suspending the effectiveness of the Registration Statement shall have been
issued under the 1933 Act and no proceedings for that purpose shall have been instituted or shall be pending or, to your knowledge or the knowledge of the Company, shall be contemplated by the Commission, and any request on the part of the
Commission for additional information shall have been complied with to the satisfaction of your counsel. 

  
 14 

 (b) Closing Date Matters. On the Closing Date, (i) the Registration Statement
and the Prospectus, as they may then be amended or supplemented, in all material respects shall conform to the requirements of the 1933 Act and the Rules and Regulations; the Company shall have complied in all material respects with Rule 430A (if it
shall have elected to rely thereon) and neither the Registration Statement nor the Prospectus, as they may then be amended or supplemented, shall contain an untrue statement of a material fact or omit to state a material fact required to be stated
therein or necessary to make the statements therein not misleading, (ii) there shall not have been, since the respective dates as of which information is given in the Registration Statement, any material adverse change in the business,
prospects, properties, assets, results of operations or condition (financial or otherwise) of the Company whether or not arising in the ordinary course of business, (iii) no action, suit or proceeding at law or in equity shall be pending or, to
the Company’s knowledge, threatened against the Company that would be required to be set forth in the Prospectus other than as set forth therein and no proceedings shall be pending or, to the knowledge of the Company, threatened against the
Company before or by any federal, state or other commission, board or administrative agency wherein an unfavorable decision, ruling or finding could materially adversely affect the business, prospects, assets, results of operations or condition
(financial or otherwise) of the Company other than as set forth in the Prospectus, (iv) the Company shall have complied with all agreements and satisfied all conditions on its part to be performed or satisfied on or prior to the Closing Date,
and (v) the representations and warranties of the Company set forth in Section 2 of this Agreement shall be accurate in all material respects as though expressly made at and as of the Closing Date. On the Closing Date, you shall have
received a certificate executed by the President of the Company, dated as of the Closing Date, to such effect and with respect to the following additional matters: (A) the Registration Statement has become effective under the 1933 Act and no
stop order suspending the effectiveness of the Registration Statement or preventing or suspending the use of the Prospectus has been issued, and no proceedings for that purpose have been instituted or are pending or, to his knowledge, threatened
under the 1933 Act; and (B) he has reviewed the Registration Statement and the Prospectus and, when the Registration Statement became effective and at all times subsequent thereto up to the delivery of such certificate, the Registration
Statement and the Prospectus and any amendments or supplements thereto contained no untrue statement of a material fact or omitted to state any material fact required to be stated therein or necessary to make the statements therein not misleading.

 (c) Opinion of Kaufman & Canoles, P.C. At the Closing Date, you shall receive the opinion of
Kaufman & Canoles, P.C., counsel for the Company, in form and substance reasonably satisfactory to you, to the effect of Exhibit A. 
 (d) Opinion of Your Counsel. At the Closing Date, you shall receive the favorable opinion of McCarter & English, LLP, your counsel, with respect to such matters as you may reasonably
require, and the Company shall have furnished to such counsel such documents as they may reasonably request for the purpose of enabling them to pass on such matters. 
 (e) Comfort Letter. At the time that this Agreement is executed by the Company, you shall have received from Cherry, Bekeart & Holland, L.L.P., a letter, dated the date hereof and in form
and substance satisfactory to you, together with signed or reproduced copies of such letter for each other Selected Dealer, containing statements and information of the type ordinarily included in accountants’ “comfort letters” with
respect to the financial statements and certain financial information of the Company contained in the Registration Statement or the Prospectus. 

  
 15 

 (f) Updated Comfort Letter. At the Closing Date, you shall have received from
Cherry, Bekeart & Holland, L.L.P., a letter, in form and substance satisfactory to you and dated as of the Closing Date, to the effect that they reaffirm the statements made in the letter furnished pursuant to Section 7(e) above,
except that the specified date referred to shall be a date not more than five (5) days prior to the Closing Date. 
 (g)
Post-Financial Developments. In the event that either of the letters to be delivered pursuant to Sections 7(e) and 7(f) above sets forth any changes, decreases or increases, it shall be a further condition to your obligations that you shall
have reasonably determined, after discussions with officers of the Company responsible for financial and accounting matters and with Cherry, Bekeart & Holland, L.L.P., that such changes, decreases or increases as are set forth in such
letter do not reflect a material adverse change in the capital stock, long-term debt, obligations under capital leases, total assets, net current assets, or shareholders’ equity of the Company as compared with the amounts shown in the latest
consolidated pro forma balance sheet of the Company, or a material adverse change in the revenues or operating income before interest, depreciation and amortization for the Company in each case as compared with the corresponding period of the prior
year. 
 (h) Additional Information. On the Closing Date, you shall have been furnished with all such documents,
certificates and opinions as you may reasonably request for the purpose of enabling your counsel to pass upon the issuance and sale of the Shares as contemplated in this Agreement and the matters referred to in Section 7.(b), and in order to
evidence the accuracy and completeness of, any of the representations, warranties or statements of the Company, the performance of any of the covenants of the Company, or the fulfillment of any of the conditions herein contained; and all proceedings
taken by the Company at or prior to the Closing Date in connection with the authorization, issuance and sale of the Shares as contemplated in this Agreement, shall be satisfactory in form and substance to you and to your counsel. The Company will
furnish you with such number of conformed copies of such opinions, certificates, letters and documents as you shall reasonably request. Any certificate signed by any officer, partner, or other official of the Company and delivered to you or your
counsel shall be deemed a representation and warranty by the Company to you as to the statements made therein. 
 (i)
Adverse Events. Subsequent to the date hereof, there shall not have occurred any of the following: (i) a suspension or material limitation in trading in securities generally on the NASDAQ Capital Market, (ii) a general moratorium on
commercial banking activities in Virginia, (iii) the outbreak or escalation of hostilities involving the United States or the declaration by the United States of a national emergency or war if the effect of any such event specified in this
clause (iii) in your reasonable judgment makes it impracticable or inadvisable to proceed with the public offering or the delivery of the Shares on the terms and in the manner contemplated in the Prospectus, or (iv) such a material adverse
change in general economic, political, financial or international conditions affecting financial markets in the United States having a material adverse impact on trading prices of securities in general, as, in your reasonable judgment, makes it
impracticable or inadvisable to proceed with the public offering of the Shares or the delivery of the Shares on the terms and in the manner contemplated in the Prospectus. 

  
 16 

 (j) FINRA Review. FINRA, upon review of the terms of the Offering, shall not have
objected to the Offering, the terms of the Offering or your participation in the Offering. 
 (k) NASDAQ Quotation. The
Shares shall be approved for quotation on the NASDAQ Capital Market. 
 If any of the conditions specified in this
Section 7 shall not have been fulfilled when and as required by this Agreement to be fulfilled, this Agreement may be terminated by you on notice to the Company at any time at or prior to the Closing Date, and such termination shall be without
liability of any party to any other party, except as provided in Sections 6 and 10. Notwithstanding any such termination, the provisions of Section 8 shall remain in effect. If the sale of the Shares, as contemplated by this Agreement, is
consummated, then the Company shall no longer be under any obligation or liability under the December 22, 2011 letter agreement, as amended, between you and the Company and such letter agreement shall be terminated. 

8. Indemnification and Contribution. 
 (a) Indemnification by the Company. Subject to the limitations set forth in this Section 8.(a), the Company will indemnify and hold you harmless against any losses, claims, damages, or
liabilities, joint or several, to which you may become subject under the 1933 Act, the 1934 Act or otherwise, insofar as such losses, claims, damages, or liabilities (or actions in respect thereof) arise out of or are based upon any breach of any
representation, warranty or covenant of the Company herein contained or any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement or the Prospectus, or any amendment or supplement thereto, or arise
out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, and will reimburse you for any legal or other expenses reasonably
incurred by you in connection with investigating or defending any such loss, claim, damage, liability, or action; provided, however, that the Company shall not be liable in any such case to the extent that any such loss, claim, damage, or liability
arises out of or is based upon an untrue statement or alleged untrue statement or omission or alleged omission made in the Registration Statement or the Prospectus, or any such amendment or supplement, in reliance upon and in conformity with written
information furnished to the Company by you expressly for use therein; provided further, that the indemnity agreement contained in this Section 8.(a) with respect to the Prospectus shall not inure to your benefit if you failed to send or give a
copy of the Prospectus to such person at or prior to the written confirmation of the sale of such Shares to such person in any case where such delivery is required by the 1933 Act or the Rules and Regulations and if the Prospectus would have cured
any untrue statement or alleged untrue statement or omission or alleged omission giving rise to such loss, claim, damage, or liability. In addition to its other obligations under this Section 8.(a), the Company agrees that, as an interim
measure during the pendency of any such claim, action, investigation, inquiry, or other proceeding arising out of or based upon any statement or omission, or any alleged statement or omission, described in this Section 8.(a), it will reimburse
you on a monthly basis for all reasonable legal and other expenses incurred in connection with investigating or defending any such claim, action, investigation, inquiry, or other proceeding (to the extent documented by reasonably itemized invoices
therefor), notwithstanding the absence of a judicial determination as to the propriety and enforceability of the Company’s obligation to reimburse you for such expenses and the possibility that such

  
 17 

 
payments might later be held to have been improper by a court of competent jurisdiction. To the extent that any such interim reimbursement payment is so held to have been improper, you shall
promptly return it to the person(s) from whom it was received. Any such interim reimbursement payments that are not made to you within thirty (30) days of a request for reimbursement shall bear interest at the prime rate (or reference rate or
other commercial lending rate for borrowers of the highest credit standing) published from time to time by The Wall Street Journal (the “Prime Rate”) from the date of such request. This indemnity agreement shall be in addition to
any liabilities that the Company may otherwise have. For purposes of this Section 8, the information set forth in the second paragraph on the front cover page (insofar as such information relates to you), and under the caption “Plan of
Distribution,” and in the Prospectus constitutes the only information furnished by you to the Company for inclusion in the Prospectus or the Registration Statement. The Company will not, without your prior written consent, settle or compromise
or consent to the entry of any judgment in any pending or threatened action or claim or related cause of action or portion of such cause of action in respect of which indemnification may be sought hereunder (whether or not you are a party to such
action or claim), unless such settlement, compromise, or consent includes an unconditional release of you from all liability arising out of such action or claim (or related cause of action or portion thereof). The indemnity agreement in this
Section 8.(a) shall extend upon the same terms and conditions to, and shall inure to the benefit of, each person, if any, who controls you within the meaning of the 1933 Act or the 1934 Act to the same extent as such agreement applies to you.

 (b) Indemnification by You. Subject to the limitations in this paragraph below, each of you, severally and not
jointly, will indemnify and hold harmless the Company against any losses, claims, damages, or liabilities to which the Company may become subject, under the 1933 Act, the 1934 Act, or otherwise, insofar as such losses, claims, damages, or
liabilities (or actions in respect thereof) arise out of or are based upon any breach of any warranty or covenant by you herein contained or any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement
or the Prospectus, or any amendment or supplement thereto, or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading,
in each case to the extent, but only to the extent, that (i) such untrue statement or alleged untrue statement or omission or alleged omission was made in the Registration Statement or the Prospectus or any such amendment or supplement thereto
in reliance upon and in conformity with written information furnished to the Company by you expressly for use therein, or (ii) you failed to deliver an amendment or supplement to the Prospectus that the Company made available to you prior to
the Closing Date and that corrected any statement or omission in the Registration Statement or the Prospectus which forms the basis for a claim against the Company, and will reimburse the Company for any legal or other expenses reasonably incurred
by the Company in connection with investigating or defending any such loss, claim, damage, liability, or action. In addition to its other obligations under this Section 8.(b), you agree that, as an interim measure during the pendency of any
such claim, action, investigation, inquiry, or other proceeding arising out of or based upon any statement or omission, or any alleged statement or omission, described in this Section 8.(b), you will reimburse the Company on a monthly basis for
all reasonable legal and other expenses incurred in connection with investigating or defending any such claim, action, investigation, inquiry, or other proceeding (to the extent documented by reasonably itemized invoices therefor), notwithstanding
the absence of a judicial determination as to the propriety and enforceability of your obligation to reimburse the 

  
 18 

 
Company for such expenses and the possibility that such payments might later been held to have been improper by a court of competent jurisdiction. To the extent that any such interim
reimbursement arrangement is so held to have been improper, the Company shall promptly return it to the person(s) from whom it was received. Any such interim reimbursement payments that are not made to the Company within thirty (30) days of a
request for reimbursement shall bear interest at the Prime Rate from the date of such request. This indemnity agreement shall be in addition to any liabilities that you may otherwise have. You will not, without the Company’s prior written
consent, settle or compromise or consent to the entry of any judgment in any pending or threatened action or claim or related cause of action or portion of such cause of action in respect of which indemnification may be sought hereunder (whether or
not the Company is a party to such action or claim), unless such settlement, compromise, or consent includes an unconditional release of the Company from all liability arising out of such action or claim (or related cause of action or portion
thereof). The indemnity agreement in this Section 8.(b) shall extend upon the same terms and conditions to, and shall inure to the benefit of, each officer and director of the Company and each person, if any, who controls the Company within the
meaning of the 1933 Act or the 1934 Act to the same extent as such agreement applies to the Company. 
 (c) Notices of
Claims; Employment of Counsel. Any party that proposes to assert the right to be indemnified under this Section 8 promptly shall notify in writing each party against which a claim is to be made under this Section 8 of the institution
of such action but the omission so to notify such indemnifying party of any such action shall not relieve it from any liability it may have to any indemnified party except (i) to the extent that the omission to notify shall have caused or
increased the indemnifying party’s liability or resulted in the forfeiture by the indemnifying party of substantial rights or defenses, and (ii) that the indemnifying party shall be relieved of its indemnity obligation for expenses of the
indemnified party incurred before the indemnifying party is notified. Such indemnifying party or parties shall assume the defense of such action, including the employment of counsel (reasonably satisfactory to the indemnified party) and payment of
fees and expenses. An indemnified party shall have the right to employ its own counsel in any such case, but the fees and expenses of such counsel shall be at the expense of such indemnified party unless the employment of such counsel shall have
been authorized in writing by the indemnifying party or parties in connection with the defense of such action or the indemnifying party or parties shall not have employed counsel to have charge of the defense of such action or such indemnified party
or parties shall have been advised by counsel that there may be defenses available to it or them that are different from or additional to those available to such indemnifying party or parties (in which case such indemnifying party or parties shall
not have the right to direct the defense of such action on behalf of the indemnified party or parties), in any of which events such fees and expenses shall be borne by such indemnifying party or parties; provided that the indemnifying party shall
not be liable for the expenses of more than one separate counsel. Anything in this paragraph to the contrary notwithstanding, an indemnifying party shall not be liable for any settlement of any such claim or action effected without its written
consent. 
 (d) Arbitration. It is agreed that any controversy arising out of the operation of the interim reimbursement
arrangements set forth in Sections 8.(a) and 8.(b) hereof, including the amounts of any requested reimbursement payments, the method of determining such amounts and the basis on which such amounts shall be apportioned among the indemnifying parties,
shall be settled by arbitration conducted pursuant to the Code of Arbitration Procedure of FINRA. 

  
 19 

 
Any such arbitration must be commenced by service of a written demand for arbitration or a written notice of intention to arbitrate, therein electing the arbitration tribunal. In the event the
party demanding arbitration does not make such designation of an arbitration tribunal in such demand or notice, then the party responding to said demand or notice is authorized to do so. Any such arbitration will be limited to the operation of the
interim reimbursement provisions contained in Sections 8.(a) and 8.(b) hereof and will not resolve the ultimate propriety or enforceability of the obligation to indemnify for expenses that is created by the provisions of Sections 8.(a) and 8.(b).

 (e) Contribution. If the indemnification provided for in Section 8.(a) or 8.(b) is unavailable to or
insufficient to hold harmless an indemnified party in respect of any losses, claims, damages, or liabilities (or actions in respect thereof) referred to therein, then the Company on the one hand and you on the other shall contribute to the amount
paid or payable as a result of such losses, claims, damages, or liabilities (or actions in respect thereof) in such proportion as is appropriate to reflect the relative benefits received by the Company on the one hand and you on the other from the
offering of the Shares. If, however, the allocation provided by the immediately preceding sentence is not permitted by applicable law, then the Company and you shall contribute to such amount paid or payable in such proportion as is appropriate to
reflect not only such relative benefits but also the relative fault of the Company on the one hand and you on the other in connection with the statements or omissions that resulted in such losses, claims, damages, or liabilities (or actions in
respect thereof), as well as any other relevant equitable considerations. The relative benefits received by the Company on the one hand and you on the other shall be deemed to be in the same proportion as the total net proceeds from the Offering
(before deducting expenses) received by the Company bear to the total selling commissions received by you in each case as set forth in the table on the cover page of the Prospectus. The relative fault shall be determined by reference to, among other
things, whether the untrue or allegedly untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the Company on the one hand or to information with respect to you and
furnished by you respectively, in writing specifically for inclusion in the Prospectus on the other and the parties’ relative intent, knowledge, access to information, and opportunity to correct or prevent such statement or omission. The
Company and you agree that it would not be just and equitable if contribution pursuant to this Section 8.(e) were determined by pro rata allocation or by any other method of allocation that does not take account of the equitable considerations
referred to above in this Section 8.(e). The amount paid or payable as a result of the losses, claims, damages or liabilities (or actions in respect thereof) referred to above in this Section 8.(e) shall be deemed to include any legal or
other expenses reasonably incurred by any such party in connection with investigating or defending any such action or claim. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the 1933 Act) with respect to
the transactions giving rise to the right of contribution provided in this Section 8.(e) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. The obligations in this Section 8.(e) for
you to contribute are several in proportion to your respective underwriting obligations and not joint. For purposes of this Section 8.(e), each person, if any, who controls you within the meaning of Section 15 of the 1933 Act shall have
the same rights to contribution as you, and each director of the Company who signed the Registration Statement, and each person, if any, who controls the Company within the meaning of Section 15 of the 1933 Act, shall have the same rights to
contribution as the Company. 

  
 20 

 9. Representations and Agreements to Survive. Except as the context otherwise
requires, all representations, warranties, covenants and agreements contained in this Agreement shall remain operative and in full force and effect regardless of any investigation made by you, or on your behalf, or by any controlling person, or by
or on behalf of the Company, and shall survive until the fifth anniversary of the Offering Termination Date and the termination of this Agreement pursuant to Section 10 hereof. 

10. Termination of Agreement. 
 (a) Termination of Agreement. You shall have the right to terminate this Agreement at any time prior to the Closing Date if any of the factors referenced in Section 7(b) hereof proves to be
incorrect or if any of the factors referenced in Section 7(i) hereof occurs. If you elect to terminate the agreement as provided in this Section 10, you shall notify the Company promptly in writing. You shall have no liability to the
Company pursuant to this Agreement or otherwise as a result of any such termination. 
 (b) Result of Termination. 

(i) If: 
 (A)
you should terminate this Agreement upon the breach by the Company of any material term of this Agreement; 
 (B) the Offering
fails to close by December 22, 2012, for reasons within the control of the Company (it being understood that to the extent the Company used reasonable good faith efforts to respond to comments on the Registration Statement from the Commission
and any other applicable regulatory body, then the Offering shall not be deemed in accordance with this Agreement to have failed for reasons within the control of the Company); 

(C) the Offering fails to close by December 22, 2012 due to reasons beyond the control of the Company or you (other than your
inability to sell the Shares due to adverse market conditions or as a result of any factor referenced in Section 7.(i) of this Agreement); or 
 (D) the Company abandons the Offering 
 then in addition to its obligations with respect to
expenses as set forth in Section 6, the Company will reimburse you on demand for all your reasonable out-of-pocket expenses and disbursements (including the fees and expenses of your counsel) actually incurred by you in reviewing the
Registration Statement and the Prospectus, and in investigating and making preparations for the marketing of the Shares. Notwithstanding any other provision of this Agreement, the amount reimbursable shall not exceed the amount of out-of-pocket
accountable expenses actually incurred by you in compliance with applicable FINRA rules. 
 (ii) if the sale of the Shares
provided for herein is not consummated for any other reason, the Company shall pay expenses as required by Section 6, and neither party shall have any additional liability to the other except for such liabilities, if any, as may exist or
thereafter arise under Section 8. 
 (iii) For purposes of clarification, if the closing of the Offering is not completed
by February 28, 2012, this Agreement will expire and the Company will have no further obligation or liability hereunder except as set forth in Sections 6, 8, and 10 hereof and the Placement Agent will have no further obligation or liability
hereunder except as set forth in Section 8 hereto. 

  
 21 

 11. Notices. 

(a) Method and Location of Notices. All communications hereunder, except as herein otherwise specifically provided, shall be in
writing and shall be sent by overnight courier, hand-delivered or telecopied and confirmed as follows: 
 To the Company:

 Wheeler Real Estate Investment Trust, Inc. 
 Riveredge North 
 2529 Virginia Beach Blvd. 

Virginia Beach, VA 23452 
 Attention: President 
 Facsimile: (757) 627-9088 

with a copy to (which shall not constitute notice): 
 Kaufman & Canoles, P.C. 
 Two James Center 

1021 East Cary Street, Suite 1400 
 Richmond, VA 23219 
 Attention: Bradley A. Haneberg, Esq. 

Facsimile: (804) 771-5777 
 To the Placement Agents: 
 Wellington Shields & Co, Inc. and Capitol
Securities Management, Inc. 
 c/o Wellington Shields & Co., Inc. 

140 Broadway, 44th Floor 
 New York, NY 10005 
 Attention: Ed Cabrera 

Telecopier No.: (212) 320-3056 
 with a copy to (which shall not constitute notice): 
 McCarter & English,
LLP 
 265 Franklin Street 
 Boston, MA 02110 
 Attention: Theodore M. Grannatt, Esquire 

Telecopier No.: (617) 449-6500 
 (b) Time of Notices. Notice shall be deemed to be given by you to the Company or by the Company to you when it is sent by overnight courier, hand-delivered or telecopied as provided in
Section 11(a). 

  
 22 

 12. Parties. This Agreement shall inure solely to the benefit of and shall be
binding upon you, the Company and the controlling persons referred to in Section 8, and their respective successors, legal representatives and assigns. No other person shall have or be construed to have a legal or equitable right, remedy or
claim under or in respect of or by virtue of this Agreement or any provision herein contained. 
 13. Governing Law,
Construction, and Time. This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware. Specified time of day refers to United States Eastern Time. Time shall be of the essence of this Agreement.

 14. Description Headings. The descriptive headings of the several sections and paragraphs of this Agreement are
inserted for convenience only and do not constitute a part of this Agreement. 
 15. Counterparts. This Agreement
may be executed in one or more counterparts, and if executed in more than one counterpart, the executed counterparts shall together constitute a single instrument. 
 [Remainder of page intentionally left blank; signature page follow] 

  
 23 

 If the foregoing correctly sets forth the understanding between you and the Company, please so indicate in
the space provided below for that purpose, whereupon this letter shall constitute a binding agreement between us. 
  

			
	Very truly yours,
	
	Wheeler Real Estate Investment Trust, Inc.
		
	By:	 	 /s/ Jon S. Wheeler

	Name:	 	Jon S. Wheeler
	Title:	 	President and Chairman
		
	Date:	 	 November 16, 2012

 Confirmed and accepted as of the date first above written: 

On behalf of the Placement Agents: 
  

			
	Wellington Shields & Co., Inc.
		
	By:	 	 /s/ Edward Cabrera

	Name:	 	Edward Cabrera
	Title:	 	Head of Investment Banking
		
	Date:	 	 November 16, 2012

	
	Capital Securities Management, Inc.
		
	By:	 	 /s/ L. McCarthy Downs, III

	Name:	 	L. McCarthy Downs, III
	Title:	 	Managing Director – Investment Banking
		
	Date:	 	 November 16, 2012

  
 24

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00210-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00210-of-00352.parquet"}]]